BC
DXCM icon

Brookfield Corp’s DexCom DXCM Stock Holding History

Brookfield Corp’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-151,252
Closed -$19.4M – 238
2023
Q2 		$19.4M Buy
151,252
+41,897
+38% +$5.07M 0.08% 95
2023
Q1 		$12.7M Sell
109,355
-36,691
-25% -$4.11M 0.05% 141
2022
Q4 		$16.5M Buy
146,046
+53,866
+58% +$5.91M 0.06% 115
2022
Q3 		$7.42M Buy
+92,180
New +$7.81M 0.03% 214

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Brookfield Corp's DXCM Position: Q3 2023 in Review

Brookfield Corp sold out of DexCom (DXCM) in Q3 2023, closing a stake of 151,252 shares — an estimated $19.4M sold.

Brookfield Corp first reported a position in DXCM in Q3 2022 and held it in 4 quarters. The position peaked at $19.4M in Q2 2023. 902 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Brookfield Corp reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 151,252 DexCom shares in Q3 2023, an estimated $19.4M.
  • Brookfield Corp first reported a position in DexCom in Q3 2022 and held it in 4 quarters.
  • Brookfield Corp's DexCom position peaked at $19.4M in Q2 2023.
  • 902 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.